EP0252716A2 - Process for production of Bishomo- Gamma-Linolenic acid and eicosapentaenoic acid - Google Patents
Process for production of Bishomo- Gamma-Linolenic acid and eicosapentaenoic acid Download PDFInfo
- Publication number
- EP0252716A2 EP0252716A2 EP87305995A EP87305995A EP0252716A2 EP 0252716 A2 EP0252716 A2 EP 0252716A2 EP 87305995 A EP87305995 A EP 87305995A EP 87305995 A EP87305995 A EP 87305995A EP 0252716 A2 EP0252716 A2 EP 0252716A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- acid
- bishomo
- culturing
- methyl
- mortierella
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C12P7/6432—Eicosapentaenoic acids [EPA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
Definitions
- the present invention relates to a new process for the production of bishomo-y-linolenic acid and eicosapentaenoic acid.
- fatty acid selected from the group consisting of bishomo-y-linolenic acid and eicosapentaenoic acid, comprising the steps of:
- the present invention provides a process for the production of a lipid containing at least one fatty acid selected from the group consisting of bishomo-y-linolenic acid and eicosapentaenoic acid, comprising the steps of:
- any strain belonging to the genus Mortierella capable of producing bishomo-y-linolenic acid and/or eicosapentaenoic acid can be used.
- Mortierella elongata IFO 8570, Mortierella exigua IFO 8571, and Mortierella hygrophila IFO 5941 can be used.
- These strains are stored in the Osaka Institute for Fermentation; 17-85, Juso-honmachi 2-chome, Yodogawa-ku, Osaka 532, Japan, and are available to the public without limitation.
- a new strain Mortierella elongata SAM 0219 can be used.
- This strain was newly isolated from a soil and identified by the present inventors, and was deposited with the Fermentation Research Institute, Agency of Industrial Science and Technology (FRI), Higashi 1-1-3, Yatabe-cho, Tsukuba-gun, Ibaraki-ken, Japan as FERM P-8703 on March 19, 1986, and transferred to International Deposition under the Budapest Treaty as FERM BP-1239 on December 22, 1986.
- Colonies grow fast, attaining a diameter of 28 to 31 mm in two days and a diameter of 65 to 72 mm in five days; colonies are lobed; the formation of aerial mycelium is scanty; sporulation is good; sporangiophores arise from the aerial hyphae; the mycelium has a garlic-like odour.
- Colonies grow fast, attaining a diameter of 27 to 31 mm in two days and a diameter of 75 to 80 mm in five days; colonies form a rosette pattern of dense lobes; much aerial mycelium is formed at the center of the colony; the reverse side of the colony is yellowish white or yellow in colour; sporulation is poor; the mycelium has a rather strong garlic-like odour.
- Colonies grow moderately fast, attaining a diameter of 22 to 24 mm in two days and a diameter of 50 to 53 mm in five days; the formation of aerial mycelium is scanty; occasionally, the aerial hyphae cling tightly to each other; sporulation is abundant: the mycelium has a garlic-like odour.
- Colonies grow fast, attaining a diameter of 27 - 29 mm in two days and a diameter of 64 to 66 mm in five days; colonies are lobed; the formation of aerial mycelium is scanty, except at the center of the colony; sporulation is good; sporangiophores arise from the aerial hyphae; the mycelium has a garlic-like odour.
- a sporangiophore is tapered and has a length of 87.5 to 320 ⁇ m, a width of 3 to 7.5 ⁇ m at the root, and a width of 1.0 to 2.5 um at the top, and often branches at the root.
- a sporangium is spherical in form, has a diameter of 15 to 30 um, contains many ascospores therein, and has an unclear color after the detaching of the sporangiospore.
- a sporangiospore is elliptical or, rarely, renal in form, has a smooth surface, and a size of 7.5 to 12.5 x 5 to 7.5 ⁇ m. A relatively large number of chlamydospores are formed.
- Chlamydosphores are present separately or, rarely, linked in a chain form. Occasionally, several mycelia appear from the edge of the chlamydosphore.
- the chlamydosphore is elliptical or subspherical in form, and has a size of 12.5 to 30 x 7.5 to 15 ⁇ m(?), or a diameter of 12.5 to 15 ⁇ m. Zygospores are not observed.
- the strain SAM-0219 of the present invention is considered to be a fungus belonging to the genus Mortierella, because a sporangium is formed at a top of a sporangiophore, the sporangium has no collumella, the sporangiospore has no appendage, and the mycelium has a garlic-like odour.
- the taxonomical properties of the strain of the present invention were compared with those of known species of the genus Mortierella according to W. Gams, "A key to the species of Mortierella, Persoonia 9: p 381 - 391, 1977.
- the colony is not velvety
- the mycelium has a garlic-like odour
- a sporangiophore has a length of 87.5 to 320 ⁇ m and branches at only its lower part and does not branch racemosely
- a sporangium contains many sporangiospore therein
- the section Hygrophila includes 22 species. According to the comparison of the present strain with these 22 species, the present strain is similar to Mortierella zychae, M. elongatula, and M. elongata.
- the strain of the present invention was compared with the above-mentioned three strains, referring to K.H. Domsch, W. Gams, and T.-H. Anderson, "Compendium of Soil Fungi", Academic Press, 1980; W. Gams, Some New or Noteworthy Species of Mortierella”; Persoonia 9: 111 - 140, 1976; G. Linnemann, "Mortierella Coemans 1863”; H. Zyche and R. Siepmann, "Mucorales Amsterdam Cardio Aller Gattitch und Arten Writzrios", p 155 - 241, J. Cramer, 1965.
- the present strain is clearly different from M.
- the present strain is different from M, elongatula in the shape and size of the sporangiosphore.
- the present strain is different from M. elongata in that sporangiophore is rather shorter, the chlamydosphore is ellipsoidal or subglobose in form, chlamydospores are rarely linked to each other in a chain form, and a small number of radiating hyphae exist.
- the present inventors concluded that such differences between the present strain and M. elongata are not sufficient to distinguish the present strain from M. elongata, and thus identified the strain of the present invention as Mortierella elongata, and designated it as strain SAM 0219.
- the medium used may be a liquid or solid medium.
- a liquid medium contains as a carbon source, for example, glucose, fructose, xylose, saccharose, maltose, soluble starch, molasses, glycerol, or mannitol.
- Nitrogen sources include organic substances such as peptones, yeast extract, meat extract, casamino acid, corn steep liquor, and inorganic substances such as sodium nitrate, ammonium nitrate, ammonium sulfate, and the like.
- inorganic salts such as phosphate salts, magnesium sulfate, ferrous sulfate and cupric sulfate, and vitamins may be included in a medium.
- concentration of these components is selected so that such components do not adversely affect the growth of the microorganism used.
- concentration of the carbon source is 0.1 to 30% by weight, preferably 1 to 10% by weight, reflective to the total weight of the medium.
- concentration of the nitrogen source is 0.01 to 5% by weight, preferably 0.1 to 2% by weight, relative to the total weight of the medium.
- hydrocarbons, fatty acids or salts thereof, or fats are preferably added to a medium in an amount of 0.01% to 20%.
- Hydrocarbons are preferably added to a medium at the start of culturing, and fatty acids or salts thereof, or fats, are preferably added at the start of and/or during culturing.
- an additive is used during culturing, it is added at one time, stepwise, or continuously.
- the culturing temperature ranges 5°C to 40°C.
- the culturing temperature is preferably 20°C to 30°C.
- the culturing temperature is preferably 10°C to 20°C from the start to the end of the culturing.
- the culturing is carried out at a temperature between 20°C and 30°C until microbial cells have a sufficient growth, and the temperature is then changed to a temperature between 10°C and 20°C to produce eicosapentaenoic acid.
- This temperature control can increase a ratio of eicosapentaenoic acid in relation to total fatty acids produced.
- a pH value of the medium is 4 to 10, preferably 6 to 9.
- Culturing is preferably carried out with aeration and/or agitation, with shaking in a liquid medium, or with standing, and is usually carried out for 2 to 10 days.
- the solid medium is composed of wheat bran, chaff or rice bran supplemented with water in an amount of 50 to 100% by weight relative to the wheat bran, chaff or rice bran. If necessary, the medium is supplemented with a small amount of nitrogen source, inorganic salts, and/or minor nutrients. Culturing is carried out at a temperature of 5°C to 40°C, preferably 20°C to 30°C, for 3 to 14 days.
- lipids containing target fatty acids are mainly intracellularly accumulated.
- target fatty acids are recovered from the cultured cells by the following procedure.
- cultured cells are collected from the cultured broth by a conventional means such as filtration or centrifugation, the cells are washed with water, and preferably, the washed cells are dried. Drying is carried out by, for example, lyophilization or air-drying. The dried cells are treated with an organic solvent or a mixture thereof, preferably under a nitrogen stream, to extract a lipid containing target fatty acids.
- the organic solvent or mixture thereof is, for example, ethers such as ethyl ether, hydrocarbons such as hexane, alcohols such as methanol or ethanol, halo-hydrocarbon such as chloroform or dichloromethane, petroleum ether, as well as a mixture of chloroform, methanol and water, or a combination of methanol and petroleum ether alternately used.
- ethers such as ethyl ether
- hydrocarbons such as hexane
- alcohols such as methanol or ethanol
- halo-hydrocarbon such as chloroform or dichloromethane
- petroleum ether as well as a mixture of chloroform, methanol and water, or a combination of methanol and petroleum ether alternately used.
- wet cells can be subjected to extraction.
- a water-miscible solvent such as methanol or ethanol, or a water-miscible solvent comprising the water-miscible solvent and water or other organic solvent is used.
- the extraction procedure is the same as described for dried cells.
- the lipid thus obtained contains target fatty acids in the form of a lipid compound such as fat.
- the target fatty acids can be isolated in the form of a free acids, they are preferably isolated in the form of an ester with a lower alcohol, for example, as methyl esters.
- target fatty acids By converting target fatty acids to such esters, each is easily separated from other lipid components, and from another target fatty acid and other fatty acids formed during culturing, such as palmitic acid, oleic acid, linoleic acid and the like, which are also esterified at the same time as the target fatty acids are esterified.
- the lipid prepared as described above is treated with a 5 to 10% hydrochloric acid solution in absolute methanol or a 10 to 50% BF 3 solution in methanol for 1 to 24 hours at a room temperature.
- the mixture thus obtained is extracted with an organic solvent such as hexane, ethyl ether or ethyl acetate, to recover methyl ester of the target fatty acids.
- the extract is dried over anhydrous sodium sulfate, and the solvent is distilled under a reduced pressure to obtain a residue mainly comprising a fatty acid mixture.
- the mixture contains, in addition to the target compounds, methyl arachidonate, methyl palmitate, methyl stearate, methyl oleate and the like.
- methyl bishomo-y-linolenate and methyl eicosapentaenoate are separately isolated by column chromatography, low temperature crystallization, a urea-adducting method, or a combination thereof.
- the isolated methyl ester of a target fatty acid is then hydrolyzed with an alkali and extracted with an organic solvent such as ethyl ether, ethyl acetate, or the like to obtain the target fatty acid in a free form.
- a target fatty acid can be obtained, without conversion to methyl ester, by alkalolysis with, for example, 5% sodium hydroxide at a room temperature for 2 to 3 hours, followed by extraction of the fatty acids from the alkalolysis product and isolation of the target fatty acid.
- the cells were extracted with a mixture of chloroform, methanol, and water, according to Bligh and Dyer's one phase extraction method, to obtain 290 mg of a whole lipid.
- the lipid was treated with a mixture of methanol and hydrochloric acid (95:5) at 20°C for three hours to esterify the arachidonic acid.
- the reaction mixture was extracted with ethyl ether to obtain 180 mg of a mixture of fatty acid methyl esters.
- the mixture was separated by column chlomatography using octa decylsilane with elution by 95% acetonitrile solution to obtain fractions containing methyl bishomo-y-linolenate.
- the amount of methyl bishomo linolenate before and after the purification per cultured broth was 0.18 m g /ml and 0.10 mg/ml respectively; and those per dried cells were 7.5 mg/g and 4.3 mg/g respectively.
- Example 2 5 i of a medium having the same composition as described in Example 1 was charged in a 15 i-volume jar fermenter, and the medium was sterilized at 120°C for 40 minutes. After cooling, the fermenter was inoculated with 200 ml of a preculture of Mortierella elongata SAM 0219 (FERM BP-1239). Culturing was carried out at 30°C for 3 days with aeration of 0.5 v.v.m. The cultured broth was then filtered to obtain 370 g of wet cells and 4050 l of a filtrate. The cells were dried to obtain 120 g of dried cells.
- the dried cells thus obtained were subjected to extraction, hydrolysis and methyl-esterification according to the same procedures as described in Example 1, to obtain 31 g of whole lipid containing 19 g of a mixture of fatty acid methyl esters.
- the amount of methyl bishomo-y-linolenate formed was 0.19 g/1 broth, and 7.9 mg/g dried cells.
- Example 2 The same procedure as described in Example 1 was carried out except that Mortierella exigua IFO 8571, and M ortierella hygrophila IFO 5941 were used. 65 mg and 93 mg of mixtures of fatty acid methyl esters were obtained respectively, and from these mixtures, 2.7 mg and 4.5 mg of methyl bishomo-y-linolenate was isolated and purified, respectively.
- the cells were then subjected to extraction, hydrolysis, and methyl-esterification according to the same procedure as described in Example 1.
- the weight of the dried cells, amount of whole lipid, amount of whole fatty acid methyl ester, content of methyl arachidonate, and amount of methyl arachidonate per cultured broth are set forth for each additive.
- the cells were extracted with a mixture of chloroform, methanol, and water, according to Bligh and Dyer's one phase extraction method, to obtain 150 mg of a whole lipid.
- the lipid was treated with a mixture of methanol and hydrochloric acid (95:5) at 20°C for three hours to esterify the arachidonic acid.
- the reaction mixture was extracted with ethyl ether to obtain 95 mg of a mixture of fatty acid methyl esters.
- the mixture contained 12% methyl palmitate, 12% methyl stearate, 24% methyl oleate, 5% methyl linoleate, 8% methyl y-linolenate, 10% methyl arachidonate, 5% methyl bishomo-y-linolenate, and 13% methyl eicosapentaenoate and 17% other components, as determined by gas chromatography.
- the mixture was separated by column chlomatography using octa decylsilane with elution by 95% acetonitrile solution to obtain fractions containing methyl eicosapentaenoate.
- methyl eicosapentaenoate preparation was compared with a commercially available authentic methyl eicosapentaenoate preparation, by gas chromatography, high performance liquid chromatography., and mass spectrometry. Both preparations showed the same results, revealing that the preparation prepared in this Example is in fact methyl eicosapentaenoate.
- the amount of methyl eicosapentaenoate before and after the purification per cultured broth was 0.25 mg/ml and 0.13 mg/ml respectively; and those per dried cells were 18 mg/g and 9 mg/g respectively.
- eicosapentaenoic acid and bishomo-y-linolenic acid can be obtained respectively.
- Example 7 (Production of eicosapentaenoic acid) 5 L of a medium having the same composition as described in Example 1 was charged in a 15 l-volume jar fermenter, and the medium was sterilized at 120°C for 40 minutes. After cooling, the fermenter was inoculated with 200 ml of a preculture of Mortierella elongata SAM 0219 (FERM BP-1239). Culturing was carried out at 30°C for 3 days with aeration of 0.5 v.v.m. The cultured broth was then filtered to obtain 150 g of wet cells and 4270 1 of a filtrate. The cells were dried to obtain 50 g of dried cells.
- the dried cells thus obtained were subjected to extraction, hydrolysis and methyl-esterification according to the same procedures as described in Example 6, to obtain 18 g of whole lipid containing 8 g of a mixture of fatty acid methyl esters.
- the mixture contained 13% methyl palmitate, 14% methyl stearate, 28% methyl oleate, 8% methyl linoleate, 8% methyl y-linolenate, 13% methyl arachidonate, 8% methyl bishomo-y-linolenate, 6% methyl eicosapentaenoate, and 17% other components, as determined by the same procedure as described in Example 6.
- the amount of methyl eicosapentaenoate formed was 0.11 g/1 broth, and 9.6 mg/g dried cells.
- Bishomo-y-linolenate can be obtained by the same procedure as described above for methyl eicosapentaenoate, from the above-mentioned mixture of fatty acid methyl esters.
- eicosapentaenoic acid and bishomo-y-linolenic acid can be obtained by hydrolyzing the methyl eicosapentaenoate and bishomo-y-linolenate.
- Example 6 The same procedure as described in Example 6 was carried out except that Mortierella exigua IFO 8571, and Mortierella hygrophila IFO 5941 were used. 47 mg and 72 mg of mixtures of fatty acid methyl esters were obtained respectively, and from these mixtures, 12 mg and 20 mg of methyl eicosapentaenoate was isolated and purified, respectively.
- the cells were then subjected to extraction, hydrolysis, and methyl-esterification according to the same procedure as described in Example 6.
- the weight of the dried cells, amount of whole lipid, amount of whole fatty acid methyl ester, content of methyl eicosapentaenoate, and amount of methyl eicosapentaenoate per cultured broth are set forth for each additive.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
- The present invention relates to a new process for the production of bishomo-y-linolenic acid and eicosapentaenoic acid.
- It is known that bishomo-y-linolenic acid and eicosapentaenoic acid are present in and can be extracted from fish oils and seaweeds or algae. However, the production process is disadvantageous in that the content of such acids in fish oils is very low, insufficient purification of the products leads to products having a fish-oil odour, and culturing of the algae is difficult. Therefore, there is a strong demand for a process for the production of bishomo-y- linolenic acid and eicosapentaenoic acid whereby such acids can be easily and industrially produced at a low cost.
- In this connection, a process for the production of bishomo-y-linolenic acid using microorganisms, and a process for the production of eicosapentaenoic acid using a microorganism belonging to the genus Mortierella, have not been hitherto considered.
- These processes, however, have the disadvantages of a low yield, long term fermentation, and a complicated production process.
- Accordingly, thé present invention provides a new process for the production of a fatty acid selected from the group consisting of bishomo-y-linolenic acid and eicosapentaenoic acid, comprising the steps of:
- - culturing a microorganism belonging to the genus Mortierella and capable of producing at least one of said fatty acids to obtain a cultured product; and
- recovering at least one of said fatty acids.
- Moreover, the present invention provides a process for the production of a lipid containing at least one fatty acid selected from the group consisting of bishomo-y-linolenic acid and eicosapentaenoic acid, comprising the steps of:
- culturing a microorganism belonging to the genus Mortierella and capable of producing at least one of said fatty acids to obtain a culture product;
- separating the cultured product to microbial cells and a supernatant;
- extracting the separated cultured product selected from the group of the microbial cells and the supernatant with an extraction agent to obtain an extract; and
- eliminating the extraction agent from the extract to obtain the lipid.
- In the present invention, as a producer microorganism, any strain belonging to the genus Mortierella capable of producing bishomo-y-linolenic acid and/or eicosapentaenoic acid can be used. For example, Mortierella elongata IFO 8570, Mortierella exigua IFO 8571, and Mortierella hygrophila IFO 5941 can be used. These strains are stored in the Osaka Institute for Fermentation; 17-85, Juso-honmachi 2-chome, Yodogawa-ku, Osaka 532, Japan, and are available to the public without limitation.
- Moreover, a new strain Mortierella elongata SAM 0219 can be used. This strain was newly isolated from a soil and identified by the present inventors, and was deposited with the Fermentation Research Institute, Agency of Industrial Science and Technology (FRI), Higashi 1-1-3, Yatabe-cho, Tsukuba-gun, Ibaraki-ken, Japan as FERM P-8703 on March 19, 1986, and transferred to International Deposition under the Budapest Treaty as FERM BP-1239 on December 22, 1986.
- The above-mentioned new strain SAM 0219 (FERM BP-1239) has the following taxonomical properties:
- Cultural characteristics on various culture media Culture condition: 25°C in the dark
- Colonies grow fast, attaining a diameter of 28 to 31 mm in two days and a diameter of 65 to 72 mm in five days; colonies are lobed; the formation of aerial mycelium is scanty; sporulation is good; sporangiophores arise from the aerial hyphae; the mycelium has a garlic-like odour.
- Colonies grow fast, attaining a diameter of 27 to 31 mm in two days and a diameter of 75 to 80 mm in five days; colonies form a rosette pattern of dense lobes; much aerial mycelium is formed at the center of the colony; the reverse side of the colony is yellowish white or yellow in colour; sporulation is poor; the mycelium has a rather strong garlic-like odour.
- Colonies grow moderately fast, attaining a diameter of 22 to 24 mm in two days and a diameter of 50 to 53 mm in five days; the formation of aerial mycelium is scanty; occasionally, the aerial hyphae cling tightly to each other; sporulation is abundant: the mycelium has a garlic-like odour.
- Colonies grow fast, attaining a diameter of 27 - 29 mm in two days and a diameter of 64 to 66 mm in five days; colonies are lobed; the formation of aerial mycelium is scanty, except at the center of the colony; sporulation is good; sporangiophores arise from the aerial hyphae; the mycelium has a garlic-like odour.
- Sporangiophore, mode of branching sporangiophore, sporangium, sporangiospore, etc., were microscopically observed for microscopic preparates and the colony per se. from various media.
- A sporangiophore is tapered and has a length of 87.5 to 320 µm, a width of 3 to 7.5 µm at the root, and a width of 1.0 to 2.5 um at the top, and often branches at the root. A sporangium is spherical in form, has a diameter of 15 to 30 um, contains many ascospores therein, and has an unclear color after the detaching of the sporangiospore. A sporangiospore is elliptical or, rarely, renal in form, has a smooth surface, and a size of 7.5 to 12.5 x 5 to 7.5 µm. A relatively large number of chlamydospores are formed. Chlamydosphores are present separately or, rarely, linked in a chain form. Occasionally, several mycelia appear from the edge of the chlamydosphore. The chlamydosphore is elliptical or subspherical in form, and has a size of 12.5 to 30 x 7.5 to 15 µm(?), or a diameter of 12.5 to 15 µm. Zygospores are not observed.
-
-
- On the basis of the above-mentioned taxonomical properties, and according to J.A. von Arx, "The Genera of Fungi Sporulating in Pure Culture" 3rd ed., J. Cramer, 1981; and K.H. Domsch, W. Gams and T.H. Anderson, "Compendium of Soil Fungi", Academic Press, 1980, the strain SAM-0219 of the present invention is considered to be a fungus belonging to the genus Mortierella, because a sporangium is formed at a top of a sporangiophore, the sporangium has no collumella, the sporangiospore has no appendage, and the mycelium has a garlic-like odour.
- Therefore, the taxonomical properties of the strain of the present invention were compared with those of known species of the genus Mortierella according to W. Gams, "A key to the species of Mortierella, Persoonia 9: p 381 - 391, 1977. As a result, because the colony is not velvety, the mycelium has a garlic-like odour, a sporangiophore has a length of 87.5 to 320 µm and branches at only its lower part and does not branch racemosely, and a sporangium contains many sporangiospore therein, the strain in question was considered to fall under the genus Mortierella, subgenus Mortierella, section Hygrophila. The section Hygrophila includes 22 species. According to the comparison of the present strain with these 22 species, the present strain is similar to Mortierella zychae, M. elongatula, and M. elongata.
- Therefore, the strain of the present invention was compared with the above-mentioned three strains, referring to K.H. Domsch, W. Gams, and T.-H. Anderson, "Compendium of Soil Fungi", Academic Press, 1980; W. Gams, Some New or Noteworthy Species of Mortierella"; Persoonia 9: 111 - 140, 1976; G. Linnemann, "Mortierella Coemans 1863"; H. Zyche and R. Siepmann, "Mucorales Eine Beschreibung Aller Gattungen und Arten dieser Pilzgruppe", p 155 - 241, J. Cramer, 1965. The present strain is clearly different from M. zychae in the length and width of the sporangiophore at the base, and the size of the sporangium. Moreover, the present strain is different from M, elongatula in the shape and size of the sporangiosphore. The present strain is different from M. elongata in that sporangiophore is rather shorter, the chlamydosphore is ellipsoidal or subglobose in form, chlamydospores are rarely linked to each other in a chain form, and a small number of radiating hyphae exist. However, the present inventors concluded that such differences between the present strain and M. elongata are not sufficient to distinguish the present strain from M. elongata, and thus identified the strain of the present invention as Mortierella elongata, and designated it as strain SAM 0219.
- Spores, mycelia, or a preculture is used as an inoculum for culturing the present strains. The medium used may be a liquid or solid medium. A liquid medium contains as a carbon source, for example, glucose, fructose, xylose, saccharose, maltose, soluble starch, molasses, glycerol, or mannitol. Nitrogen sources include organic substances such as peptones, yeast extract, meat extract, casamino acid, corn steep liquor, and inorganic substances such as sodium nitrate, ammonium nitrate, ammonium sulfate, and the like. If necessary, inorganic salts such as phosphate salts, magnesium sulfate, ferrous sulfate and cupric sulfate, and vitamins may be included in a medium. The concentration of these components is selected so that such components do not adversely affect the growth of the microorganism used. Practically, the concentration of the carbon source is 0.1 to 30% by weight, preferably 1 to 10% by weight, reflective to the total weight of the medium. The concentration of the nitrogen source is 0.01 to 5% by weight, preferably 0.1 to 2% by weight, relative to the total weight of the medium.
- To enhance the production of target fatty acids, in addition to the above-mentioned medium components, hydrocarbons, fatty acids or salts thereof, or fats, are preferably added to a medium in an amount of 0.01% to 20%. Hydrocarbons are preferably added to a medium at the start of culturing, and fatty acids or salts thereof, or fats, are preferably added at the start of and/or during culturing. When such an additive is used during culturing, it is added at one time, stepwise, or continuously.
- The culturing temperature ranges 5°C to 40°C. For the production of bishomo-y-linolenic acid, the culturing temperature is preferably 20°C to 30°C. For the production of eicosapentaenoic acid, the culturing temperature is preferably 10°C to 20°C from the start to the end of the culturing. Alternatively, the culturing is carried out at a temperature between 20°C and 30°C until microbial cells have a sufficient growth, and the temperature is then changed to a temperature between 10°C and 20°C to produce eicosapentaenoic acid. This temperature control, can increase a ratio of eicosapentaenoic acid in relation to total fatty acids produced. A pH value of the medium is 4 to 10, preferably 6 to 9.
- Culturing is preferably carried out with aeration and/or agitation, with shaking in a liquid medium, or with standing, and is usually carried out for 2 to 10 days.
- When culturing is carried out on a solid medium, the solid medium is composed of wheat bran, chaff or rice bran supplemented with water in an amount of 50 to 100% by weight relative to the wheat bran, chaff or rice bran. If necessary, the medium is supplemented with a small amount of nitrogen source, inorganic salts, and/or minor nutrients. Culturing is carried out at a temperature of 5°C to 40°C, preferably 20°C to 30°C, for 3 to 14 days.
- During culturing, lipids containing target fatty acids are mainly intracellularly accumulated. When a liquid medium is used, target fatty acids are recovered from the cultured cells by the following procedure.
- After culturing, cultured cells are collected from the cultured broth by a conventional means such as filtration or centrifugation, the cells are washed with water, and preferably, the washed cells are dried. Drying is carried out by, for example, lyophilization or air-drying. The dried cells are treated with an organic solvent or a mixture thereof, preferably under a nitrogen stream, to extract a lipid containing target fatty acids. The organic solvent or mixture thereof is, for example, ethers such as ethyl ether, hydrocarbons such as hexane, alcohols such as methanol or ethanol, halo-hydrocarbon such as chloroform or dichloromethane, petroleum ether, as well as a mixture of chloroform, methanol and water, or a combination of methanol and petroleum ether alternately used. By distilling off the solvent, a lipid containing concentrated target fatty acids is obtained.
- Alternatively, wet cells can be subjected to extraction. In such a case, a water-miscible solvent such as methanol or ethanol, or a water-miscible solvent comprising the water-miscible solvent and water or other organic solvent is used. The extraction procedure is the same as described for dried cells.
- The lipid thus obtained contains target fatty acids in the form of a lipid compound such as fat. Although the target fatty acids can be isolated in the form of a free acids, they are preferably isolated in the form of an ester with a lower alcohol, for example, as methyl esters. By converting target fatty acids to such esters, each is easily separated from other lipid components, and from another target fatty acid and other fatty acids formed during culturing, such as palmitic acid, oleic acid, linoleic acid and the like, which are also esterified at the same time as the target fatty acids are esterified. To obtain methyl esters of the target fatty acids, for example, the lipid prepared as described above is treated with a 5 to 10% hydrochloric acid solution in absolute methanol or a 10 to 50% BF3 solution in methanol for 1 to 24 hours at a room temperature.
- The mixture thus obtained is extracted with an organic solvent such as hexane, ethyl ether or ethyl acetate, to recover methyl ester of the target fatty acids. Next, the extract is dried over anhydrous sodium sulfate, and the solvent is distilled under a reduced pressure to obtain a residue mainly comprising a fatty acid mixture. The mixture contains, in addition to the target compounds, methyl arachidonate, methyl palmitate, methyl stearate, methyl oleate and the like. From the mixture, methyl bishomo-y-linolenate and methyl eicosapentaenoate are separately isolated by column chromatography, low temperature crystallization, a urea-adducting method, or a combination thereof.
- The isolated methyl ester of a target fatty acid is then hydrolyzed with an alkali and extracted with an organic solvent such as ethyl ether, ethyl acetate, or the like to obtain the target fatty acid in a free form.
- Alternatively, a target fatty acid can be obtained, without conversion to methyl ester, by alkalolysis with, for example, 5% sodium hydroxide at a room temperature for 2 to 3 hours, followed by extraction of the fatty acids from the alkalolysis product and isolation of the target fatty acid.
- The present invention will now be further illustrated by, but is by no means limited to, the following examples.
- 50 ml of a medium containing 5% glucose, 0.5% peptone, 0.3% yeast extract and 0.3% malt extract (pH 6.0) was prepared and charged into a 500 ml-volume Sakaguchi flask, and the whole was autoclaved for 20 minutes at 120°C. After cooling, Mortierella elongata SAM 0219 (FERM BP-1239) was inoculated the medium, and then cultured for 5 days at 28°C with reciprocal shaking at 110 rpm. After culturing, the cultured broth was filtered to recover cells. The cells were then completely washed with water and lyophilized to obtain 1.2 g of dried cells. The cells were extracted with a mixture of chloroform, methanol, and water, according to Bligh and Dyer's one phase extraction method, to obtain 290 mg of a whole lipid. The lipid was treated with a mixture of methanol and hydrochloric acid (95:5) at 20°C for three hours to esterify the arachidonic acid. The reaction mixture was extracted with ethyl ether to obtain 180 mg of a mixture of fatty acid methyl esters. The mixture was separated by column chlomatography using octa decylsilane with elution by 95% acetonitrile solution to obtain fractions containing methyl bishomo-y-linolenate. After the fractions were combined, the solvent was distilled off on a rotary evaporator to obtain 5.2 mg of purified methyl bishomo-y-linolenate. The methyl bishomo-y-linolenate preparation thus obtained was compared with a methyl bishomo-y-linolenate prepared from a commercially available bishomo-y-linolenic acid, by gas chromatography, high performance liquid chromatography, and mass spectrometry. Both preparations showed the same results, revealing that the preparation prepared in this Example is in fact methyl bishomo-y-linolenate. The amount of methyl bishomo linolenate before and after the purification per cultured broth was 0.18 mg/ml and 0.10 mg/ml respectively; and those per dried cells were 7.5 mg/g and 4.3 mg/g respectively.
- 5 i of a medium having the same composition as described in Example 1 was charged in a 15 i-volume jar fermenter, and the medium was sterilized at 120°C for 40 minutes. After cooling, the fermenter was inoculated with 200 ml of a preculture of Mortierella elongata SAM 0219 (FERM BP-1239). Culturing was carried out at 30°C for 3 days with aeration of 0.5 v.v.m. The cultured broth was then filtered to obtain 370 g of wet cells and 4050 ℓ of a filtrate. The cells were dried to obtain 120 g of dried cells. The dried cells thus obtained were subjected to extraction, hydrolysis and methyl-esterification according to the same procedures as described in Example 1, to obtain 31 g of whole lipid containing 19 g of a mixture of fatty acid methyl esters. The amount of methyl bishomo-y-linolenate formed was 0.19 g/1 broth, and 7.9 mg/g dried cells.
- On the other hand, 4,050 ml of the above-mentioned filtrate was subjected to extraction, hydrolysis and methyl-esterification to obtain 172 mg of a mixture of fatty acid methyl esters including 5% by weight of methyl bishomo-y-linolenate relative to a weight of the mixture.
- The same procedure as described in Example 1 was carried out except that Mortierella exigua IFO 8571, and Mortierella hygrophila IFO 5941 were used. 65 mg and 93 mg of mixtures of fatty acid methyl esters were obtained respectively, and from these mixtures, 2.7 mg and 4.5 mg of methyl bishomo-y-linolenate was isolated and purified, respectively.
- 20 ml of a medium containing 2% glucose, 1% yeast extract, and 0.2% Tween 20, as well as an additive, i.e., 0.5% of a different kind of hydrocarbons, sodium salt of fatty acid or lipid listed in the following Table 1 (pH 6.0) was charged in each 100 ml-volume Erlenmeyer flask, and the flasks were autoclaved at 120°C for 20 minutes. Mortierella elongata SAM 0219 (FERM BP-1239) were inoculated into the medium and then cultured for 5 days at 28°C with rotary shaking at 200 rpm. The cultured broths were separately filtrated to obtain cells. The cells were then subjected to extraction, hydrolysis, and methyl-esterification according to the same procedure as described in Example 1. The weight of the dried cells, amount of whole lipid, amount of whole fatty acid methyl ester, content of methyl arachidonate, and amount of methyl arachidonate per cultured broth are set forth for each additive.
- As seen from the Table 1, the addition of hydrocarbons, salts of fatty acids and lipid increased the production of bishomo-y-linolenic acid by 2 to 20% relative to the no-addition control.
- 20 ml of medium containing 2% glucose and 1% yeast extract was charged in 100 ml-volume Elrenmeyer flasks, and the flasks were autoclaved at 120°C for 20 minutes. Mortierella elongata SAM 0219 (FERM BP-1239) was inoculated into the medium, and then incubated at 28°C for 4 days. After the addition of 100 mg of a different kind of sodium salt of fatty acid or lipid into each flask, incubation was continued at 28°C for an additional 2 days. The cultures were separately filtered to obtain cells, and the cells were then subjected to extraction, hydrolysis, and methyl-esterification according to the same procedure as described in Example 1. The amount of methyl bishomo-y-linolenate per dried cells and per cultured broth was as set forth for each additive in Table 2.
- As seen from Table 2, the addition of salts of fatty acids and lipids at the fourth day of culturing increased the production of bishomo-y-linolenic acid by 10 to 80% relative to the no-addition control.
- 50 ml of a medium containing 5% glucose, 0.5% peptone, 0.3% yeast extract and 0.3% malt extract (pH 6.0) was prepared and charged into a 500 ml-volume Sakaguchi flask, and the whole was autoclaved for 20 minutes at 120°C. After cooling, Mortierella elongata SAM 0219 (FERM- BP-1239) was inoculated into the medium, and then cultured for 5 days at 28°C with reciprocal shaking at 110 rpm. After culturing, the cultured broth was filtered to recover cells. The cells were then completely washed with water and lyophilized to obtain 0.7 g of dried cells. The cells were extracted with a mixture of chloroform, methanol, and water, according to Bligh and Dyer's one phase extraction method, to obtain 150 mg of a whole lipid. The lipid was treated with a mixture of methanol and hydrochloric acid (95:5) at 20°C for three hours to esterify the arachidonic acid. The reaction mixture was extracted with ethyl ether to obtain 95 mg of a mixture of fatty acid methyl esters. The mixture contained 12% methyl palmitate, 12% methyl stearate, 24% methyl oleate, 5% methyl linoleate, 8% methyl y-linolenate, 10% methyl arachidonate, 5% methyl bishomo-y-linolenate, and 13% methyl eicosapentaenoate and 17% other components, as determined by gas chromatography. The mixture was separated by column chlomatography using octa decylsilane with elution by 95% acetonitrile solution to obtain fractions containing methyl eicosapentaenoate. After the fractions were combined, the solvent was distilled off on a rotary evaporator to obtain 6.5 mg of purified methyl eicosapentaenoate. The methyl eicosapentaenoate preparation thus obtained was compared with a commercially available authentic methyl eicosapentaenoate preparation, by gas chromatography, high performance liquid chromatography., and mass spectrometry. Both preparations showed the same results, revealing that the preparation prepared in this Example is in fact methyl eicosapentaenoate. The amount of methyl eicosapentaenoate before and after the purification per cultured broth was 0.25 mg/ml and 0.13 mg/ml respectively; and those per dried cells were 18 mg/g and 9 mg/g respectively.
- According to the same procedure as described above for methyl eicosapentaenoate, from the above-mentioned mixture of fatty acid methyl esters, methyl bishomo-y-linolenate can be obtained.
- Moreover, by hydrolyzing the methyl eicosapentaenoate and methyl bishomo-y-linolenate, eicosapentaenoic acid and bishomo-y-linolenic acid can be obtained respectively.
- Example 7. (Production of eicosapentaenoic acid) 5 L of a medium having the same composition as described in Example 1 was charged in a 15 ℓ-volume jar fermenter, and the medium was sterilized at 120°C for 40 minutes. After cooling, the fermenter was inoculated with 200 ml of a preculture of Mortierella elongata SAM 0219 (FERM BP-1239). Culturing was carried out at 30°C for 3 days with aeration of 0.5 v.v.m. The cultured broth was then filtered to obtain 150 g of wet cells and 4270 1 of a filtrate. The cells were dried to obtain 50 g of dried cells. The dried cells thus obtained were subjected to extraction, hydrolysis and methyl-esterification according to the same procedures as described in Example 6, to obtain 18 g of whole lipid containing 8 g of a mixture of fatty acid methyl esters. The mixture contained 13% methyl palmitate, 14% methyl stearate, 28% methyl oleate, 8% methyl linoleate, 8% methyl y-linolenate, 13% methyl arachidonate, 8% methyl bishomo-y-linolenate, 6% methyl eicosapentaenoate, and 17% other components, as determined by the same procedure as described in Example 6. The amount of methyl eicosapentaenoate formed was 0.11 g/1 broth, and 9.6 mg/g dried cells.
- On the other hand, 4,270 ml of the above-mentioned filtrate was subjected to extraction, hydrolysis and methyl-esterification to obtain 82 mg of a mixture of fatty acid methyl esters including 7% by weight of methyl eicosapentaenoate relative to a weight of the mixture.
- Bishomo-y-linolenate can be obtained by the same procedure as described above for methyl eicosapentaenoate, from the above-mentioned mixture of fatty acid methyl esters.
- Moreover, eicosapentaenoic acid and bishomo-y-linolenic acid can be obtained by hydrolyzing the methyl eicosapentaenoate and bishomo-y-linolenate.
- The same procedure as described in Example 6 was carried out except that Mortierella exigua IFO 8571, and Mortierella hygrophila IFO 5941 were used. 47 mg and 72 mg of mixtures of fatty acid methyl esters were obtained respectively, and from these mixtures, 12 mg and 20 mg of methyl eicosapentaenoate was isolated and purified, respectively.
- 20 ml of a medium containing 2% glucose, 1% yeast extract, and 0.2% Tween 20, as well as an additive, i.e., 0.5% of a different kind of hydrocarbons, sodium salt of fatty acid or lipid listed in the following Table 1 (pH 6.0) was charged in each 100 ml-volume Erlenmeyer flask, and the flasks were autoclaved at 120°C for 20 minutes. Mortierella elongata SAM 0219 (FERM BP-1239) were inoculated the medium and then cultured for 5 days at 28°C with rotary shaking at 200 rpm. The cultured broths were separately filtrated to obtain cells. The cells were then subjected to extraction, hydrolysis, and methyl-esterification according to the same procedure as described in Example 6. The weight of the dried cells, amount of whole lipid, amount of whole fatty acid methyl ester, content of methyl eicosapentaenoate, and amount of methyl eicosapentaenoate per cultured broth are set forth for each additive.
- As seen from Table 3, the addition of linseed oil or sodium linoleate increased the amount of eicosapentaenoic acid produced to 0.44 mg and 0..32 mg/ml medium respectively. Also, the addition of hydrocarbons, salts of fatty acid or lipid remarkably increased the production of eicosapentanoic acid, but the no-addition control provided no detectable fatty acids.
- 20 ml of a medium containing 2% glucose and 1% yeast extract was charged in 100 ml-volume Elrenmeyer flasks, and the flasks were autoclaved at 120°C for 20 minutes. Mortierella elongata SAM 0219 (FERM BP-1239) was inoculated the medium, and the incubated at 28°C for 5 days, and then l2°C for 4 days. The culture was filtered to obtain cells. The cells were then subjected to extraction, hydrolysis, and methyl-esterification according to the same procedure as described in Example 6. 75 mg of a mixture of fatty acid methyl esters containing 9% methyl eicosapentaenoate was obtained.
- 20 ml of a medium containing 2% glucose and 1% yeast extract was charged in 100 ml-volume Elrenmeyer flasks, and the flasks were autoclaved at 120°C for 20 minutes. Mortierella elongata SAM 0219 (FERM BP-1239) was inoculated the medium, and then incubated at 28°C for 4 days. After the addition of 100 mg of a different kind of sodium salt of fatty acid or lipid into each flask, incubation was continued at 28°C for an additional 2 days. The cultures were separately filtered to obtain cells. The cells were then subjected to extraction, hydrolysis, and methyl-esterification according to the same procedure as described in Example 6.
-
- As seen from Table 4, the addition of salts of fatty acids and lipids at the fourth day of the culturing provided the production of 0.006 mg to 0.25 g/ml medium of eicosapentaenoic acid; while the no-addition control provided no detectable eicosapentaenoic acid.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT87305995T ATE84316T1 (en) | 1986-07-08 | 1987-07-07 | PROCESS FOR THE PREPARATION OF BISHOMO-GAMMALINOLENIC ACID AND EICOSAPENTAENIC ACID. |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61158651A JPH0712315B2 (en) | 1986-07-08 | 1986-07-08 | Eicosapentaenoic acid and method for producing lipid containing the same |
| JP158651/86 | 1986-07-08 | ||
| JP158650/86 | 1986-07-08 | ||
| JP61158650A JPH0722513B2 (en) | 1986-07-08 | 1986-07-08 | Bishomo-γ-linolenic acid and method for producing lipid containing the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EP0252716A2 true EP0252716A2 (en) | 1988-01-13 |
| EP0252716A3 EP0252716A3 (en) | 1988-10-05 |
| EP0252716B1 EP0252716B1 (en) | 1993-01-07 |
Family
ID=26485695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP87305995A Expired - Lifetime EP0252716B1 (en) | 1986-07-08 | 1987-07-07 | Process for production of bishomo- gamma-linolenic acid and eicosapentaenoic acid |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US5401646A (en) |
| EP (1) | EP0252716B1 (en) |
| CA (1) | CA1317901C (en) |
| DE (1) | DE3783396T2 (en) |
| ES (1) | ES2052564T3 (en) |
| GR (1) | GR3006757T3 (en) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0304049A3 (en) * | 1987-08-19 | 1990-01-31 | Idemitsu Petrochemical Co. Ltd. | Method for the production of lipids containing bis-homo-linolenic acid |
| US4916066A (en) * | 1987-12-21 | 1990-04-10 | Suntory Limited | Process for production of bishomo-gamma-linolenic acid |
| EP0399494A1 (en) * | 1989-05-24 | 1990-11-28 | Idemitsu Petrochemical Co. Ltd. | Process for production of dihomo-gamma-linolenic acid and inhibitor for unsaturation reaction at delta 5-position of fatty acid |
| EP0522470A1 (en) * | 1991-07-11 | 1993-01-13 | Idemitsu Petrochemical Co., Ltd. | Triglyceride-containing dry cell fragments and method of preparing them |
| US5591446A (en) * | 1989-04-04 | 1997-01-07 | Beiersdorf, A.G. | Methods and agents for the prophylaxis of atopy |
| CN1035627C (en) * | 1991-07-30 | 1997-08-13 | 中国科学院沈阳应用生态研究所 | Preparation method of r-subanesthesia and biological agent based on it |
| WO1998008967A1 (en) * | 1996-08-30 | 1998-03-05 | Suntory Limited | Process for preparing fat or oil containing unsaturated fatty acid |
| WO1998029558A1 (en) | 1996-12-27 | 1998-07-09 | Suntory Limited | Media for culturing microorganisms and process for producing unsaturated fatty acids or lipids containing the same |
| EP0825263A3 (en) * | 1996-08-23 | 1999-09-15 | Suntory Limited | Process for producing omega-9 highly unsaturated fatty acid and lipid containing the same |
| WO2002064807A3 (en) * | 2001-02-12 | 2003-03-20 | Nutrinova | Method for producing $g(g)-linolenic acids from a ciliate culture by adding suitable precursor molecules to said culture medium |
| EP0972844A4 (en) * | 1997-03-04 | 2003-03-26 | Suntory Ltd | PROCESS FOR THE PREPARATION OF A HIGHLY UNSATURATED FATTY ACID (AGHI) AND LIPID CONTAINING THE SAME |
| US7863024B2 (en) | 2002-04-26 | 2011-01-04 | Suntory Holdings Limited | Process for producing highly unsaturated fatty acid-containing lipid |
| US9611488B2 (en) | 2011-07-21 | 2017-04-04 | Dsm Ip Assets B.V. | Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof |
| US9668499B2 (en) | 2010-01-19 | 2017-06-06 | Dsm Ip Assets B.V. | Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof |
| US10362794B2 (en) | 2009-03-19 | 2019-07-30 | Dsm Ip Assets B.V. | Thraustochytrids, fatty acid compositions, and methods of making and uses thereof |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2347094C (en) * | 1999-08-13 | 2015-02-03 | Suntory Limited | Microorganisms that extracellularly secrete lipids and methods of producing lipid and lipid vesicles encapsulating lipids using said microorganisms |
| US8685679B2 (en) * | 2004-11-04 | 2014-04-01 | E I Du Pont De Nemours And Company | Acyltransferase regulation to increase the percent of polyunsaturated fatty acids in total lipids and oils of oleaginous organisms |
| US7550286B2 (en) * | 2004-11-04 | 2009-06-23 | E. I. Du Pont De Nemours And Company | Docosahexaenoic acid producing strains of Yarrowia lipolytica |
| SG176463A1 (en) | 2005-02-22 | 2011-12-29 | Univ Michigan | Small molecule inhibitors of mdm2 and uses thereof |
| US20090117253A1 (en) * | 2007-10-03 | 2009-05-07 | E. I. Du Pont De Nemours And Company | Peroxisome biogenesis factor protein (pex) disruptions for altering polyunsaturated fatty acids and total lipid content in oleaginous eukaryotic organisms |
| EP2749946B1 (en) * | 2008-07-16 | 2015-09-09 | Nissan Chemical Industries, Ltd. | Positive resist composition;patttern forming method; microlens and planarization film therefrom; solid-state imaging device, liquid crystal display device and led display device comprising the same |
| WO2011133610A1 (en) | 2010-04-22 | 2011-10-27 | E. I. Du Pont De Nemours And Company | Method for obtaining polyunsaturated fatty acid-containing compositions from microbial biomass |
| US20120040076A1 (en) | 2010-08-11 | 2012-02-16 | E. I. Du Pont De Nemours And Company | Aquaculture feed compositions |
| US20120207912A1 (en) | 2010-08-11 | 2012-08-16 | E.I. Du Pont De Nemours And Company | Aquaculture meat products |
| WO2012021703A1 (en) | 2010-08-11 | 2012-02-16 | E. I. Du Pont De Nemours And Company | A sustainable aquaculture feeding strategy |
| AU2011293180B2 (en) | 2010-08-26 | 2017-03-02 | E. I. Du Pont De Nemours And Company | Recombinant microbial host cells for high eicosapentaenoic acid production |
| US9040730B2 (en) * | 2011-02-11 | 2015-05-26 | E I Du Pont De Nemours And Company | Purification of triglyceride oil from microbial sources using short path distillation |
| AU2013371074B2 (en) | 2012-12-24 | 2018-07-26 | Qualitas Health Inc. | Eicosapentaenoic acid (EPA) formulations |
| JP6026709B1 (en) | 2014-12-25 | 2016-11-16 | 国立大学法人京都大学 | Process for producing novel ω3 unsaturated fatty acid enzyme and eicosapentaenoic acid |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4485173A (en) * | 1981-01-19 | 1984-11-27 | Cpc International Inc. | Preparation of fats and oils |
| JPS59205979A (en) * | 1983-05-11 | 1984-11-21 | Agency Of Ind Science & Technol | Preparation of mold of microorganism and lipid |
| DE3470061D1 (en) * | 1984-02-09 | 1988-04-28 | Agency Ind Science Techn | A method for the preparation of a fungal body and a lipid rich in gamma-linolenic acid therefrom |
| JPS60168391A (en) * | 1984-02-09 | 1985-08-31 | Agency Of Ind Science & Technol | Production of gamma-linolenic acid-containing lipid and gamma- linolenic acid |
| JPS60259192A (en) * | 1984-06-05 | 1985-12-21 | Agency Of Ind Science & Technol | Production of microbial lipid |
| FR2574089B1 (en) * | 1984-12-03 | 1987-04-10 | Inst Nat Sante Rech Med | PROCESS FOR THE PRODUCTION OF FATTY ACIDS, IN PARTICULAR G-LINOLEIC ACID FROM TETRAHYMENA, PRODUCTS OBTAINED AND MEDICINAL OR FOOD PREPARATION CONTAINING G-LINOLENIC ACID OR DERIVATIVES THEREOF AS ANTI-AGGREGATION AGENT |
| JPH0716424B2 (en) * | 1985-10-01 | 1995-03-01 | ライオン株式会社 | Method for producing arachidonic acid-containing lipid |
-
1987
- 1987-07-07 ES ES87305995T patent/ES2052564T3/en not_active Expired - Lifetime
- 1987-07-07 EP EP87305995A patent/EP0252716B1/en not_active Expired - Lifetime
- 1987-07-07 DE DE8787305995T patent/DE3783396T2/en not_active Expired - Lifetime
- 1987-07-07 CA CA000541498A patent/CA1317901C/en not_active Expired - Lifetime
-
1993
- 1993-01-08 GR GR920403245T patent/GR3006757T3/el unknown
- 1993-08-16 US US08/106,637 patent/US5401646A/en not_active Expired - Fee Related
Cited By (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0304049A3 (en) * | 1987-08-19 | 1990-01-31 | Idemitsu Petrochemical Co. Ltd. | Method for the production of lipids containing bis-homo-linolenic acid |
| US5034321A (en) * | 1987-08-19 | 1991-07-23 | Idemitsu Petrochemical Co., Ltd. | Method for the production of lipids containing bis-homo-γ-linolenic acid |
| US4916066A (en) * | 1987-12-21 | 1990-04-10 | Suntory Limited | Process for production of bishomo-gamma-linolenic acid |
| EP0322227A3 (en) * | 1987-12-21 | 1990-07-18 | Suntory Limited | Process for production of bishomo-gamma-linolenic acid |
| US5591446A (en) * | 1989-04-04 | 1997-01-07 | Beiersdorf, A.G. | Methods and agents for the prophylaxis of atopy |
| EP0399494A1 (en) * | 1989-05-24 | 1990-11-28 | Idemitsu Petrochemical Co. Ltd. | Process for production of dihomo-gamma-linolenic acid and inhibitor for unsaturation reaction at delta 5-position of fatty acid |
| US5093249A (en) * | 1989-05-24 | 1992-03-03 | Idemitsu Petrochemical Co., Ltd. | Process for production of dihomo-γ-linolenic acid and inhibitor for unsaturation reaction at Δ5-position of fatty acid |
| EP0522470A1 (en) * | 1991-07-11 | 1993-01-13 | Idemitsu Petrochemical Co., Ltd. | Triglyceride-containing dry cell fragments and method of preparing them |
| CN1035627C (en) * | 1991-07-30 | 1997-08-13 | 中国科学院沈阳应用生态研究所 | Preparation method of r-subanesthesia and biological agent based on it |
| EP0825263A3 (en) * | 1996-08-23 | 1999-09-15 | Suntory Limited | Process for producing omega-9 highly unsaturated fatty acid and lipid containing the same |
| US6150144A (en) * | 1996-08-23 | 2000-11-21 | Suntory Limited | Process for producing omega-9 highly unsaturated fatty acid and lipid containing the same |
| US6812020B1 (en) | 1996-08-23 | 2004-11-02 | Suntory Limited | Process for producing omega-9 highly unsaturated fatty acid and lipid containing the same |
| WO1998008967A1 (en) * | 1996-08-30 | 1998-03-05 | Suntory Limited | Process for preparing fat or oil containing unsaturated fatty acid |
| US9493798B2 (en) | 1996-08-30 | 2016-11-15 | Suntory Holdings Limited | Process for producing unsaturated fatty acid-containing oils |
| US20060252736A1 (en) * | 1996-08-30 | 2006-11-09 | Suntory Limited | Process for producing unsaturated fatty acid-containing oils |
| US9464305B2 (en) | 1996-08-30 | 2016-10-11 | Suntory Holdings Limited | Process for producing unsaturated fatty acid-containing oils |
| US8841097B2 (en) | 1996-08-30 | 2014-09-23 | Suntory Holdings Limited | Process for producing unsaturated fatty acid-containing oils |
| US7091244B1 (en) | 1996-08-30 | 2006-08-15 | Suntory Limited | Process for preparing fat or oil containing unsaturated fatty acid |
| WO1998029558A1 (en) | 1996-12-27 | 1998-07-09 | Suntory Limited | Media for culturing microorganisms and process for producing unsaturated fatty acids or lipids containing the same |
| EP0972844A4 (en) * | 1997-03-04 | 2003-03-26 | Suntory Ltd | PROCESS FOR THE PREPARATION OF A HIGHLY UNSATURATED FATTY ACID (AGHI) AND LIPID CONTAINING THE SAME |
| EP2175031A3 (en) * | 1997-03-04 | 2010-07-07 | Suntory Holdings Limited | Process for preparing highly unsaturated fatty acid and lipid containing highly unsaturated fatty acid |
| US6958229B2 (en) | 1997-03-04 | 2005-10-25 | Suntory Limited | Method for producing highly unsaturated fatty acids and lipid containing same |
| US7081356B2 (en) | 2001-02-12 | 2006-07-25 | Nutrinova Nutrition Specialities & Food Ingredients Gmbh | Method for producing γ-linolenic acids from a ciliate culture by adding suitable precursor molecules to said culture medium |
| WO2002064807A3 (en) * | 2001-02-12 | 2003-03-20 | Nutrinova | Method for producing $g(g)-linolenic acids from a ciliate culture by adding suitable precursor molecules to said culture medium |
| US7863024B2 (en) | 2002-04-26 | 2011-01-04 | Suntory Holdings Limited | Process for producing highly unsaturated fatty acid-containing lipid |
| US10362794B2 (en) | 2009-03-19 | 2019-07-30 | Dsm Ip Assets B.V. | Thraustochytrids, fatty acid compositions, and methods of making and uses thereof |
| US9668499B2 (en) | 2010-01-19 | 2017-06-06 | Dsm Ip Assets B.V. | Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof |
| US9611488B2 (en) | 2011-07-21 | 2017-04-04 | Dsm Ip Assets B.V. | Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| DE3783396D1 (en) | 1993-02-18 |
| US5401646A (en) | 1995-03-28 |
| EP0252716A3 (en) | 1988-10-05 |
| CA1317901C (en) | 1993-05-18 |
| GR3006757T3 (en) | 1993-06-30 |
| DE3783396T2 (en) | 1993-07-29 |
| EP0252716B1 (en) | 1993-01-07 |
| ES2052564T3 (en) | 1994-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5401646A (en) | Process for production of bishomo-gamma-linolenic acid and eicosapentaenoic acid | |
| US5204250A (en) | Process for production of arachidonic acid | |
| EP0322227B1 (en) | Process for production of bishomo-gamma-linolenic acid | |
| Shimizu et al. | Microbial conversion of an oil containing α‐linolenic acid to an oil containing eicosapentaenoic acid | |
| US6280982B1 (en) | Process for production of dihomo-γ-linolenic acid and lipid containing same | |
| CA1340433C (en) | Process for production of arachidonic acid | |
| EP0276541B1 (en) | Process for production of arachidonic acid | |
| CA2079367C (en) | Process for production of omega 9 type polyunsaturated fatty acid | |
| EP2071019A1 (en) | Method for the cultivation of microoranisms of the order thraustochytriales | |
| AU743992B2 (en) | Process for producing omega-9 highly unsaturated fatty acid and lipid containing the same | |
| EP0355972B1 (en) | Process for production of fatty acids having high degree of unsaturation | |
| EP0276982A2 (en) | Process for production of fatty acids having high degree of unsaturation | |
| EP0253556A2 (en) | Process for production of gamma-linolenic acid | |
| EP0332423B1 (en) | Progress for production of highly unsaturated fatty acid having odd number of carbon atoms | |
| JPH0712315B2 (en) | Eicosapentaenoic acid and method for producing lipid containing the same | |
| JPH0722513B2 (en) | Bishomo-γ-linolenic acid and method for producing lipid containing the same | |
| JP2848810B2 (en) | Method for producing arachidonic acid-rich fat | |
| SK34795A3 (en) | Manufacturing process of microbial lipids at production of l-lactic acid | |
| HK1007052B (en) | Process for production of dihomo-alpha-linolenic acid and lipid containing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE |
|
| PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
| AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE |
|
| 17P | Request for examination filed |
Effective date: 19890317 |
|
| 17Q | First examination report despatched |
Effective date: 19910904 |
|
| ITTA | It: last paid annual fee | ||
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE |
|
| REF | Corresponds to: |
Ref document number: 84316 Country of ref document: AT Date of ref document: 19930115 Kind code of ref document: T |
|
| REF | Corresponds to: |
Ref document number: 3783396 Country of ref document: DE Date of ref document: 19930218 |
|
| ET | Fr: translation filed | ||
| ITF | It: translation for a ep patent filed | ||
| REG | Reference to a national code |
Ref country code: GR Ref legal event code: FG4A Free format text: 3006757 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed | ||
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2052564 Country of ref document: ES Kind code of ref document: T3 |
|
| EPTA | Lu: last paid annual fee | ||
| EAL | Se: european patent in force in sweden |
Ref document number: 87305995.0 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 19970626 Year of fee payment: 11 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19980731 |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20060629 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20060705 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20060712 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20060713 Year of fee payment: 20 Ref country code: LU Payment date: 20060713 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20060716 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20060719 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20060724 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20060731 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20060911 Year of fee payment: 20 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20070707 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 |
|
| NLV7 | Nl: ceased due to reaching the maximum lifetime of a patent |
Effective date: 20070707 |
|
| EUG | Se: european patent has lapsed | ||
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20070709 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20070706 |
|
| BE20 | Be: patent expired |
Owner name: *SUNTORY LTD Effective date: 20070707 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20070709 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20060705 Year of fee payment: 20 |




